Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
2022;34:1054-1063.e7
These approaches aim either to mimic beneficial metabolic signalling or to prevent amyloid-driven -cell injury
Trends May Be More Informative Than One Reading Comparing results obtained under similar conditions can help show whether: Kidney function remains stable Electrolytes are changing A1C and glucose are improving Triglycerides and cholesterol are responding Iron or vitamin status is declining Liver-related markers are improving or worsening Test Conditions Matter Results may vary because of: Fasting or recent meals Hydration Vomiting or diarrhea Recent strenuous exercise Alcohol intake Acute illness or inflammation Supplements, including biotin Other prescription medications Menstruation or pregnancy Age, sex, muscle mass, and recent weight change Differences in laboratory methods Do not stop, reduce, or increase a GLP-1 medication or another prescription drug based solely on direct-access laboratory results
*The Food and Drug Administration has not evaluated these statements
Although bariatric surgery led to more weight loss, GLP-1 RAs were associated with better outcomes, suggesting benefits may extend beyond just weight reduction
US$ 21.74
US$ 23.10
US$ 29.50
